ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

TMS Treatment for OCD Offers Effective Relief for Patients Resistant to First-Line Treatments

Columbus, OH (Newsworthy.ai) Saturday Jan 27, 2024 @ 7:00 AM Eastern —

Optimum TMS, a leading provider of Transcranial Magnetic Stimulation (TMS) therapy, is introducing an innovative treatment option for individuals grappling with Obsessive-Compulsive Disorder (OCD). Research indicates that approximately 45-55% of patients experience a significant reduction in OCD symptoms following TMS treatment.

TMS therapy utilizes a magnetic field to target deeper brain regions associated with OCD, offering a safe and effective solution for patients who have not responded well to traditional treatments. With over 2 million adults diagnosed with OCD each year, Optimum TMS aims to provide relief for those resistant to first-line therapies.

Throughout the TMS therapy process, patients undergo 29 sessions with an MRI machine. While some individuals may experience mild side effects such as headaches or gastrointestinal discomfort, these effects typically diminish after 1-2 months. The positive effects of TMS treatment for OCD can last between six months to one year after completing the full course of treatment.

Optimum TMS provides personalized treatment plans for individuals seeking relief from OCD symptoms. Weekly assessments and access to additional support resources ensure that patients receive comprehensive care throughout their treatment journey. Priced at $362 per session, Optimum TMS also offers flexible payment plans and financing options to make TMS treatment accessible to individuals in need.

As pioneers in TMS therapy, Optimum TMS is dedicated to advancing the field through ongoing clinical research. Their studies consistently demonstrate the efficacy of TMS treatment for OCD, even in patients who have failed multiple medications and therapy.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here TMS Treatment for OCD Offers Effective Relief for Patients Resistant to First-Line Treatments.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.